Abionyx Pharma Forms Manufacturing Partnership with Olon for CER-001

MT Newswires · 2d ago
01:37 AM EDT, 10/07/2026 (MT Newswires) -- Abionyx Pharma (ABNX.PA) established a manufacturing partnership with Italian contract development and manufacturing organization Olon to advance the development and commercialization of CER-001 as a treatment for sepsis. The Paris-listed biopharmaceutical company said Wednesday that the partnership will initially focus on two validation batches of CER-001. Subject to regulatory approval, the deal will also satisfy the industrial requirements for the future commercialization of the drug.